Phase II 5-Azacytidine Plus VPA Plus ATRA

Clinical trial NCT00326170 · COMPLETED

Trial details

NCT number: NCT00326170
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndrome Acute Myelogenous Leukemia

Start date: 2005-07-01
Primary completion: 2007-07-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.